What exactly is the Tesamorelin + Ipamorelin blend, and why do research programs pick the 10mg+5mg tier?
Each vial contains 10mg of Tesamorelin — a stabilized 44-amino-acid growth-hormone-releasing-hormone (GHRH) analog with an N-terminal trans-3-hexenoyl group that resists proteolytic cleavage — co-lyophilized with 5mg of Ipamorelin, a selective ghrelin-receptor (GHS-R1a) pentapeptide agonist. The 10mg+5mg per vial tier is Prescott’s only pre-mixed Tesamorelin/Ipamorelin format, sized for programmes running combined-signal designs without wanting to reconstitute two separate vials on every dosing event.
What does this specific lot’s CoA cover?
Blend lots are analysed by reverse-phase HPLC to confirm both peptide identities and their relative proportions, and by mass spectrometry against the expected Tesamorelin and Ipamorelin monoisotopic masses. Lot-specific certificates of analysis are being catalogued and will appear on the product page as they are released.
How do I reconstitute a Tesamorelin + Ipamorelin blend vial?
- Bring the vial to room temperature and wipe the stopper with an alcohol swab.
- Draw 1 to 2 mL of bacteriostatic water into a sterile syringe.
- Direct the diluent down the vial wall so the co-lyophilized cake wets uniformly.
- Rotate — do not shake — until fully clear; both peptides go into solution readily.
- Refrigerate at 2 to 8 °C and use within 30 days.
Why the 2:1 Tesamorelin/Ipamorelin ratio?
The 10mg Tesamorelin / 5mg Ipamorelin ratio reflects the way pre-clinical GH-axis literature typically pairs the two: a larger GHRH-arm signal drives the pulse, and a smaller GHS-R-arm agonist amplifies it. Because Ipamorelin is selective for GHS-R1a without cortisol or prolactin spillover, doubling the GHRH mass relative to the GHS mass keeps the combined-signal experiment biased toward the GHRH input while still capturing the synergy.
How does the TP15 blend compare with standalone Tesamorelin or CJC No-DAC + Ipa?
Standalone TSM10 gives the GHRH arm only — appropriate when the ghrelin-receptor arm is a separate experimental variable. The CP10 blend swaps in short-acting CJC-1295 No-DAC (~30-minute half-life) as the GHRH partner, which yields a sharper, briefer GHRH pulse. TP15 uses Tesamorelin instead, whose protease-resistant backbone gives a more stable GHRH signal across the dosing window — the right pick when the study design needs both peptides working together over a longer plasma exposure.
What ships in the box, and how fast?
- 10 lyophilized Tesamorelin + Ipamorelin blend vials (10mg Tesamorelin + 5mg Ipamorelin per vial)
Orders placed before 14:00 PT dispatch same business day from the British Columbia warehouse; Canadian orders land in 2 to 4 business days.
